Anda belum login :: 02 Jun 2025 19:42 WIB
Detail
ArtikelBeneficial Effects of Combined Treatment With Rosiglitazone and Exercise on Cardiovascular Risk Factors in Patients With Type 2 Diabetes  
Oleh: Kadoglou, Nikolaos P.E. ; Iliadis, Fotios ; Liapis, Christos D. ; Perrea, Despina ; Angelopoulou, Nikoleta ; Alevizos, Miltiadis
Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: Diabetes Care vol. 30 no. 09 (Sep. 2007), page 2242.
Topik: HOMA-IR; homeostasis model assessment of insulin resistance ; IL; interleukin ; TNF; tumor necrosis factor
Ketersediaan
  • Perpustakaan FK
    • Nomor Panggil: D05.K.2007.03
    • Non-tandon: 1 (dapat dipinjam: 0)
    • Tandon: tidak ada
    Lihat Detail Induk
Isi artikelPhysical activity attenuates metabolic and cardiovascular maladaptations in diabetes by improving glycemic control, insulin resistance, cardiorespiratory fitness, and adipocytokines levels (adiponectin, resistin, tumor necrosis factor [TNF]-, and interleukin [IL]-6) (1,2). Likewise, thiazolidinediones favorably influence the above indexes (3,4). We hypothesized that the combination of exercise training and rosiglitazone, a thiazolidinedione, would confer additional benefits in the metabolic and cardiovascular profiles of diabetic patients, exceeding those of each treatment alone......
Opini AndaKlik untuk menuliskan opini Anda tentang koleksi ini!

Kembali
design
 
Process time: 0 second(s)